Table 1 Characterization of the cohort of 193 prostate cancer samples
Characteristics | n (%) |
|---|---|
Age (years) | |
< 50 | 11 (5.69) |
50 - 70 | 160 (82.9) |
>70 | 21 (11.4) |
Preoperative PSA (ng/ml) | |
< 10 | 114 (60.6) |
10 ≥ PSA < 20 | 50 (26.5) |
≥ 20 | 24 (12.9) |
TNM stage (pathologic) | |
II | 95 (49.2) |
III | 86 (44.6) |
IV | 8 (6.23) |
Gleason score | |
6 (3 + 3) | 102 (52.8) |
7 (3 + 4) | 46 (23.8) |
7 (4 + 3) | 19 (9.8) |
8 - 10 | 26 (13.5) |
Angiolymphatic invasion | |
Presence | 44 (23.2) |
Absence | 146 (76.9) |
Extraprostatic extension | |
Presence | 41 (21.7) |
Absence | 148 (78.3) |
Positive margin | |
Presence | 68 (21.6) |
Absence | 122 (78.4) |
Seminal vesicle invasion | |
Presence | 22 (11.6) |
Absence | 168 (88.4) |
Positive lymph node | |
Presence | 10 (5.44) |
Absence | 174 (94.6) |
Biochemical recurrence | |
Presence | 115 (60.5) |
Absence | 75 (39.5) |